OnKure Therapeutics, Inc. (OKUR) — Capital Reinvestment Ratio

Latest as of December 2023: 0.01x

OnKure Therapeutics, Inc. (OKUR) has a Capital Reinvestment Ratio of 0.01x as of December 2023, meaning it reinvests 0% of its operating cash flow ($9.38 Million) in capital expenditures ($50.00K). See OKUR net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$9.38 Million
USD

Capital Expenditures

$50.00K
USD

Data as of

Dec 2023
Most recent filing

Annual Capital Reinvestment Ratio for OnKure Therapeutics, Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for OnKure Therapeutics, Inc. from None to None. For live market cap and broader valuation context, see OKUR market cap overview.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow